FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to oncology and coagulology, and relates to the correction of hypercoagulation that occurs when cisplatin is administered by injection. To correct hypercoagulation, one should intragastrically inject a hemlock extract at a dose of 30 mg/kg into experimental animals after a single injection of cisplatin within the period from the 6th day to the 9th day.
EFFECT: invention ensures effective correction of hypercoagulation due to a complex of furocoumarins of the administered extract.
1 cl, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR ENHANCING ANTIMETASTATIC ACTION OF CISPLATIN AND REDUCING ITS SIDE EFFECT ON HAEMOSTASIS SYSTEM | 2023 |
|
RU2825825C1 |
| METHOD OF MODELING HEMOSTASIS SYSTEM DISORDERS | 2019 |
|
RU2714597C1 |
| MEANS WITH ANTI-INFLAMMATORY AND ANALGETIC ACTION | 2016 |
|
RU2629607C1 |
| METHOD FOR PRESCRIBING INDIVIDUAL ANTITHROMBOTIC THERAPY IN ACUTE AND EARLY PERIODS OF SPINOCRONOUS INJURY OF THE CERVICAL SPINE | 2021 |
|
RU2770633C1 |
| METHOD OF MODELING HEMOSTASIS DISORDERS IN COMBINED LUNG LESIONS WITH BACTERIAL INFLAMMATION AND PULMONARY VASCULAR THROMBOSIS | 2023 |
|
RU2800645C1 |
| METHOD FOR EXTRACTING THE SUM OF FUROCOUMARINS FROM CELL CULTURE OF HEMLOCK PATCHY (CONIUM MACULATUM L.) | 2018 |
|
RU2713118C1 |
| MEDICATION POSSESSING HAEMOSTIMULATING, ANTIMUTAGENIC, ANTITUMOUR, CEREBROPROTECTIVE, ANTIHYPOXIC, NOOTROPIC, ANXIOLYTIC AND ANTINEUROTIC ACTION | 2010 |
|
RU2438691C1 |
| MEANS FOR CORRECTION OF VIOLATIONS IN HEMOGENESIS ERYTHROID LINEAGE CAUSED BY CYSTOSTATIC IMPACT | 2016 |
|
RU2634572C1 |
| ANALGESIC (VERSIONS) | 2006 |
|
RU2367461C2 |
| METHOD FOR EXTRACTING SUM OF FUROCOUMARINS FROM HEMLOCK HERB (CONIUM MACULATUM L., FAMILY APIACEAE) | 2018 |
|
RU2706119C1 |
